Because it has also been reported that neurons of PD patients have an increase in TrkB.T1 expression (Fenner et al., 2014), it will be of interest to test whether sporadic PD patients have RBFOX1 upregulation and, if that is the case, an association with increased TrkB.T1 receptor levels. This evidence concerns the gene NTRK2 and Parkinson disease.